FDA's Ozempic Warning Ignored by Users.

The FDA has warned that compounded versions of semaglutide, a drug used for weight loss and diabetes treatment, could cause dangerous side effects. However, the high cost of name-brand options has led some patients to ignore the warning and turn to compounded versions. Compounding pharmacies are not regulated by the FDA, and the active ingredients in compounded semaglutide may not be FDA-approved. Despite the risks, many patients are turning to compounded versions due to the cost. Doctors warn that the potential harm of compounded semaglutide may not be worth the low cost.